Paper363262
Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants.
Benson AM and 5 others. Cancer Res, 1978. Cited by 388 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants. Papers, record 363262. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/363262
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anisoles | Major topic |
| Benzopyrenes | Major topic |
| Butylated Hydroxyanisole | Major topic |
| Ethoxyquin | Major topic |
| Glutathione Transferase | Major topic |
| Liver | Major topic |
| Mutagens | Major topic |
| Quinolines | Major topic |
| Animals | |
| Biotransformation | |
| Female | |
| Male | |
| Mice | |
| Rats | |
| Salmonella typhimurium |
Source PubMed
Cited by54
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 388 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42218132 | Tipping the balance: NRF2's dual role in ferroptotic fate. | Oncogenesis | 2026 | https://conductscience.org/library/papers/42218132 | PubMed |
| 38205365 | Nrf2, A Target for Precision Oncology in Cancer Prognosis and Treatment. | J Cancer Prev | 2023 | https://conductscience.org/library/papers/38205365 | PubMed |
| 36837862 | Effects of Medicinal Plants and Phytochemicals in Nrf2 Pathways during Inflammatory Bowel Diseases and Related Colorectal Cancer: A Comprehensive Review. | Metabolites | 2023 | https://conductscience.org/library/papers/36837862 | PubMed |
| 34102289 | Targeting NRF2 to treat cancer. | Semin Cancer Biol | 2021 | https://conductscience.org/library/papers/34102289 | PubMed |
| 33276631 | NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of Tumourigenesis. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33276631 | PubMed |
| 32400766 | The role of natural products in revealing NRF2 function. | Nat Prod Rep | 2020 | https://conductscience.org/library/papers/32400766 | PubMed |
| 32284348 | The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway. | Mol Cell Biol | 2020 | https://conductscience.org/library/papers/32284348 | PubMed |
| 31782059 | Nrf2 in liver toxicology. | Arch Pharm Res | 2020 | https://conductscience.org/library/papers/31782059 | PubMed |
| 30256716 | Modulating NRF2 in Disease: Timing Is Everything. | Annu Rev Pharmacol Toxicol | 2019 | https://conductscience.org/library/papers/30256716 | PubMed |
| 29082352 | NRF2-targeted therapeutics: New targets and modes of NRF2 regulation. | Curr Opin Toxicol | 2016 | https://conductscience.org/library/papers/29082352 | PubMed |
| 27520103 | Effect of antioxidants on the photooxidation of fatty acids. | Lipids | 1983 | https://conductscience.org/library/papers/27520103 | PubMed |
| 27497696 | Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants. | Arch Biochem Biophys | 2017 | https://conductscience.org/library/papers/27497696 | PubMed |
| 26122708 | Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. | Free Radic Biol Med | 2015 | https://conductscience.org/library/papers/26122708 | PubMed |
| 24278719 | The Role of Sulfhydryl Reactivity of Small Molecules for the Activation of the KEAP1/NRF2 Pathway and the Heat Shock Response. | Scientifica (Cairo) | 2012 | https://conductscience.org/library/papers/24278719 | PubMed |
| 24263569 | Interaction between dietary selenium and 2-acetylaminofluorene in the rat. | Biol Trace Elem Res | 1983 | https://conductscience.org/library/papers/24263569 | PubMed |
| 23555802 | Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway. | PLoS One | 2013 | https://conductscience.org/library/papers/23555802 | PubMed |
| 22966037 | Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. | Pharmacol Rev | 2012 | https://conductscience.org/library/papers/22966037 | PubMed |
| 22737387 | Endoplasmic Reticulum Stress and Unfolded Protein Response Pathways: Potential for Treating Age-related Retinal Degeneration. | J Ophthalmic Vis Res | 2012 | https://conductscience.org/library/papers/22737387 | PubMed |
| 19793802 | Nrf2: friend or foe for chemoprevention? | Carcinogenesis | 2010 | https://conductscience.org/library/papers/19793802 | PubMed |
| 12717849 | Effect of vanadium on colonic aberrant crypt foci induced in rats by 1,2 dimethyl hydrazine. | World J Gastroenterol | 2003 | https://conductscience.org/library/papers/12717849 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GSTK1 | 373156 | PubTator's text mining | https://conductscience.org/library/genes/373156 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/363262
GET https://conductscience.org/api/papers/v1/363262/cited_by?page=2